Alvotech

Alvotech

Yahoo Finance • 4 days ago

Alvotech advances 18%, accelerating post-earnings rally

[Modern Medicine Research Laboratory: Diverse Team of Multi-Ethnic Young Scientists Passes Samples in Petri Dish. Advanced Lab with High-Tech Equipment, Microbiology Researchers Design, Develop Drugs] gorodenkoff/iStock via Getty Images A... Full story

Yahoo Finance • 4 days ago

BofA starts bullish Alvotech coverage on biosimilar launch cycle

Investing.com -- BofA Securities initiated coverage of Alvotech S.A. with a "buy" rating and a $7 price objective, versus the stock's $4.43 price as of Monday, after the FDA's closure of its inspection of the company's Reykjavik manufactur... Full story

Yahoo Finance • 7 days ago

Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets

Alvotech REYKJAVIK, ICELAND (August 21, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced a strategic... Full story

Yahoo Finance • 8 days ago

Alvotech Q2 Earnings Call Highlights

Key Points Interested in Alvotech? Here are five stocks we like better. First-half results declined as manufacturing slowed during facility and quality-system improvements, with revenue falling to $212 million and adjusted EBITDA to $47 m... Full story

Yahoo Finance • 2 months ago

Biotech firm Alvotech expands capital access with $75M term loan facility

Alvotech (ALVO [https://seekingalpha.com/symbol/ALVO]) announced an amendment to its existing credit agreement [https://seekingalpha.com/pr/20569593-alvotech-further-strengthens-liquidity-by-securing-term-loan-facility-of-75-million], secu... Full story

Yahoo Finance • 2 months ago

Alvotech (ALVO): 10 Penny Stocks With Explosive Growth Potential

Alvotech (NASDAQ:ALVO) is one of the penny stocks with explosive growth potential. On June 18, Alvotech closed its underwritten public offering of 26,066,667 ordinary shares at $3.75 per share, raising ~$98 million in gross proceeds. This... Full story

Yahoo Finance • 2 months ago

Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement

REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients wo... Full story

Yahoo Finance • 2 months ago

Hlutafjárútboði Alvotech í Bandaríkjunum lokið og umsjónaraðilar nýttu sér að fullu kauprétt á viðbótarbréfum svo heildarandvirði að meðtöldum hlutum keyptum af evrópskum fagfjárfestum nemur 165 milljónum dollara

REYKJAVÍK (18. júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að lokið væri sölutryggðu hlutafjárútboði í Bandaríkjunum. Fjárfestar fengu afhenta þann 17. júní sl. 26.066.667 almenna hluti á verðinu 3,75 dollarar á hlut. Í... Full story

Yahoo Finance • 2 months ago

Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares

REYKJAVIK, Iceland, June 18, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients wo... Full story

Yahoo Finance • 2 months ago

At a glance: stocks gapping down premarket

[Wall Street sign, New York City, USA] mbbirdy/E+ via Getty Images Here's a quick look at the stocks that are seeing gap-down moves before the bell Tuesday. Stock index futures (SPX [https://seekingalpha.com/symbol/SPX]) were muted on Tu... Full story

Yahoo Finance • 2 months ago

Alvotech Prices $152 Million Offering To Advance Biosimilar Portfolio; Stock Down

(RTTNews) - Alvotech (ALVO), a company focused on developing and manufacturing biosimilar medicines, has priced a combined $152 million capital raise through a public offering of ordinary shares and a concurrent private placement. The fina... Full story

Yahoo Finance • 2 months ago

Alvotech prices $85M stock offering, plans additional raise via private placement

* Alvotech (ALVO [https://seekingalpha.com/symbol/ALVO]) priced [https://seekingalpha.com/pr/20552228-alvotech-announces-pricing-of-152-million-public-offering-of-ordinary-shares-and-concurrent] its previously announced underwritten publ... Full story

Yahoo Finance • 2 months ago

Alvotech Announces Pricing of $152 Million Public Offering of Ordinary Shares and Concurrent Private Placement

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients w... Full story

Yahoo Finance • 2 months ago

Alvotech tilkynnir um verð og úthlutun hlutabréfa að andvirði um 152 milljónir dollara í útboði í Bandaríkjunum og lokuðu útboði til fagfjárfesta á Evrópska efnahagssvæðinu

REYKJAVÍK (16. júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) kynnti í dag ákvörðun um verð og úthlutun í áður boðuðu sölutryggðu hlutafjárútboði í Bandaríkjunum. Úthlutað var 22.666.667 almennum hlutum á verðinu 3,75 dollarar á hlut. Bréf... Full story

Yahoo Finance • 2 months ago

Alvotech efnir til útboðs á hlutabréfum í Bandaríkjunum að andvirði 125 milljónir dollara samhliða lokuðu útboði til fagfjárfesta á Evrópska efnahagssvæðinu

REYKJAVÍK (15. júní 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að félagið efni til sölutryggðs hlutafjárútboðs í Bandaríkjunum. Félagið hefur jafnframt veitt umsjónaraðilum útboðsins heimild til þess að kaupa til viðbótar al... Full story

Yahoo Finance • 3 months ago

Alvotech (ALVO) Receives FDA Form 483 Following Routine Facility Inspection

Alvotech (NASDAQ:ALVO) is one of the most promising penny stocks according to Wall Street analysts. On May 11, Alvotech announced the completion of a routine FDA surveillance inspection at its manufacturing facility in Reykjavik, Iceland.... Full story

Yahoo Finance • 3 months ago

Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®

Alvotech REYKJAVIK, Iceland, June 04, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announc... Full story

Yahoo Finance • 3 months ago

Alvotech (ALVO) Q4 2025 Earnings Transcript

Image source: The Motley Fool. DATE Thursday, March 19, 2026 at 8 a.m. ET CALL PARTICIPANTS Executive Chairman — Robert Wessman Chief Executive Officer — Lisa Graver Chief Financial Officer — Linda Jonsdottir Chief Scientific Officer —... Full story

Yahoo Finance • 4 months ago

Alvotech (ALVO) Q1 2026 Earnings Transcript

Image source: The Motley Fool. DATE Thursday, May 7, 2026 at 8 a.m. ET CALL PARTICIPANTS Executive Chairman — Robert Wessman Chief Executive Officer — Lisa Graver Chief Financial Officer — Linda Jonsdottir Chief Legal and IR Officer —... Full story

Yahoo Finance • 4 months ago

Alvotech Q1 Earnings Call Highlights

Alvotech logo Key Points FDA inspection at Alvotech’s Reykjavik facility is underway and Biologics License Application resubmissions for multiple biosimilars are in the final stage, with the company planning resubmissions in Q2 and targe... Full story